1010113-01-5

Basic information

• Product Name: tert-butyl 4-((6-(4-(methylsulfonyl)phenyl)pyridine-3-yloxy)methyl)piperidin-1-carboxylate
• Synonyms: tert-butyl 4-((6-(4-(methylsulfonyl)phenyl)pyridine-3-yloxy)methyl)piperidin-1-carboxylate
• CAS NO: 1010113-01-5
• Molecular Weight: 446.568
• Mol File: 1010113-01-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-((6-(4-(methylsulfonyl)phenyl)pyridine-3-yloxy)methyl)piperidin-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-((6-(4-(methylsulfonyl)phenyl)pyridine-3-yloxy)methyl)piperidin-1-carboxylate(1010113-01-5)
• EPA Substance Registry System: tert-butyl 4-((6-(4-(methylsulfonyl)phenyl)pyridine-3-yloxy)methyl)piperidin-1-carboxylate(1010113-01-5)

Safety Data

• Hazardous Substances Data: 1010113-01-5(Hazardous Substances Data)

Upstream product

• 1010115-38-4 tert-butyl 4-(((6-chloropyridin-3-yl)oxy)methyl)piperidine-1-carboxylate 
• 149104-88-1 4-methanesulphonylphenylboronic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 161975-39-9 tert-butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate 
• 6457-49-4 4-piperidinemethanol 
• 194872-09-8 4-(methylsulfonylmethyl)piperidine-1-carboxylic acid tert-butyl ester 
• 123855-51-6 tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate 

Downstream Products

• 1032823-42-9 5-Ethyl-2-{4-[({6-[4-(methylsulfonyl)phenyl]-3-pyridinyl}oxy)methyl]-1-piperidinyl}pyrimidine 
• 1032823-37-2 1-Methylethyl 4-[({6-[4-(methylsulfonyl)phenyl]-3-pyridinyl}oxy)methyl]-1-piperidinecarboxylate 
• 1010115-40-8 2-[4-(methylsulfonyl)phenyl]-5-[(4-piperidinylmethyl)oxy]pyridine 
• 1010115-41-9 2-[4-(methylsulfonyl)phenyl]-5-[(4-piperidinylmethyl)oxy]pyridine trifluoroacetate 

Relevant articles and documents

PIPERIDINE DERIVATIVES FOR GPR119 AGONIST

The present invention relates to novel piperidine derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel piperidine derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.

BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.